The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Genomic Medicine-Global Market Insights and Sales Trends 2024
Synopsis
The global Genomic Medicine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Genomic Medicine in various end use industries. The expanding demands from the Hospitals, Clinics, Academic Institutions and Research Institutions, are propelling Genomic Medicine market. Oncology, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Cardiology segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Genomic Medicine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Genomic Medicine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Genomic Medicine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Genomic Medicine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Genomic Medicine covered in this report include BioMed Central, Cleveland Clinic, MD Anderson Cancer Center, Manchester Centre for Genomic Medicine and Center for Genomic Medicine, etc.
The global Genomic Medicine market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
BioMed Central
Cleveland Clinic
MD Anderson Cancer Center
Manchester Centre for Genomic Medicine
Center for Genomic Medicine
Global Genomic Medicine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Genomic Medicine market, Segment by Type:
Oncology
Cardiology
Pediatrics
Endocrinology
Respiratory Medicine
Other
Global Genomic Medicine market, by Application
Hospitals
Clinics
Academic Institutions
Research Institutions
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Genomic Medicine companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Genomic Medicine market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Genomic Medicine in various end use industries. The expanding demands from the Hospitals, Clinics, Academic Institutions and Research Institutions, are propelling Genomic Medicine market. Oncology, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Cardiology segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Genomic Medicine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Genomic Medicine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Genomic Medicine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Genomic Medicine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Genomic Medicine covered in this report include BioMed Central, Cleveland Clinic, MD Anderson Cancer Center, Manchester Centre for Genomic Medicine and Center for Genomic Medicine, etc.
The global Genomic Medicine market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
BioMed Central
Cleveland Clinic
MD Anderson Cancer Center
Manchester Centre for Genomic Medicine
Center for Genomic Medicine
Global Genomic Medicine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Genomic Medicine market, Segment by Type:
Oncology
Cardiology
Pediatrics
Endocrinology
Respiratory Medicine
Other
Global Genomic Medicine market, by Application
Hospitals
Clinics
Academic Institutions
Research Institutions
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Genomic Medicine companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Genomic Medicine
1.1 Genomic Medicine Market Overview
1.1.1 Genomic Medicine Product Scope
1.1.2 Genomic Medicine Market Status and Outlook
1.2 Global Genomic Medicine Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Genomic Medicine Market Size by Region (2018-2029)
1.4 Global Genomic Medicine Historic Market Size by Region (2018-2023)
1.5 Global Genomic Medicine Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Genomic Medicine Market Size (2018-2029)
1.6.1 North America Genomic Medicine Market Size (2018-2029)
1.6.2 Europe Genomic Medicine Market Size (2018-2029)
1.6.3 Asia-Pacific Genomic Medicine Market Size (2018-2029)
1.6.4 Latin America Genomic Medicine Market Size (2018-2029)
1.6.5 Middle East & Africa Genomic Medicine Market Size (2018-2029)
2 Genomic Medicine Market by Type
2.1 Introduction
2.1.1 Oncology
2.1.2 Cardiology
2.1.3 Pediatrics
2.1.4 Endocrinology
2.1.5 Respiratory Medicine
2.1.6 Other
2.2 Global Genomic Medicine Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Genomic Medicine Historic Market Size by Type (2018-2023)
2.2.2 Global Genomic Medicine Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Genomic Medicine Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Genomic Medicine Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Genomic Medicine Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Genomic Medicine Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Genomic Medicine Revenue Breakdown by Type (2018-2029)
3 Genomic Medicine Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Academic Institutions
3.1.4 Research Institutions
3.2 Global Genomic Medicine Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Genomic Medicine Historic Market Size by Application (2018-2023)
3.2.2 Global Genomic Medicine Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Genomic Medicine Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Genomic Medicine Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Genomic Medicine Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Genomic Medicine Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Genomic Medicine Revenue Breakdown by Application (2018-2029)
4 Genomic Medicine Competition Analysis by Players
4.1 Global Genomic Medicine Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Genomic Medicine as of 2022)
4.3 Date of Key Players Enter into Genomic Medicine Market
4.4 Global Top Players Genomic Medicine Headquarters and Area Served
4.5 Key Players Genomic Medicine Product Solution and Service
4.6 Competitive Status
4.6.1 Genomic Medicine Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 BioMed Central
5.1.1 BioMed Central Profile
5.1.2 BioMed Central Main Business
5.1.3 BioMed Central Genomic Medicine Products, Services and Solutions
5.1.4 BioMed Central Genomic Medicine Revenue (US$ Million) & (2018-2023)
5.1.5 BioMed Central Recent Developments
5.2 Cleveland Clinic
5.2.1 Cleveland Clinic Profile
5.2.2 Cleveland Clinic Main Business
5.2.3 Cleveland Clinic Genomic Medicine Products, Services and Solutions
5.2.4 Cleveland Clinic Genomic Medicine Revenue (US$ Million) & (2018-2023)
5.2.5 Cleveland Clinic Recent Developments
5.3 MD Anderson Cancer Center
5.3.1 MD Anderson Cancer Center Profile
5.3.2 MD Anderson Cancer Center Main Business
5.3.3 MD Anderson Cancer Center Genomic Medicine Products, Services and Solutions
5.3.4 MD Anderson Cancer Center Genomic Medicine Revenue (US$ Million) & (2018-2023)
5.3.5 Manchester Centre for Genomic Medicine Recent Developments
5.4 Manchester Centre for Genomic Medicine
5.4.1 Manchester Centre for Genomic Medicine Profile
5.4.2 Manchester Centre for Genomic Medicine Main Business
5.4.3 Manchester Centre for Genomic Medicine Genomic Medicine Products, Services and Solutions
5.4.4 Manchester Centre for Genomic Medicine Genomic Medicine Revenue (US$ Million) & (2018-2023)
5.4.5 Manchester Centre for Genomic Medicine Recent Developments
5.5 Center for Genomic Medicine
5.5.1 Center for Genomic Medicine Profile
5.5.2 Center for Genomic Medicine Main Business
5.5.3 Center for Genomic Medicine Genomic Medicine Products, Services and Solutions
5.5.4 Center for Genomic Medicine Genomic Medicine Revenue (US$ Million) & (2018-2023)
5.5.5 Center for Genomic Medicine Recent Developments
6 North America
6.1 North America Genomic Medicine Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Genomic Medicine Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Genomic Medicine Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Genomic Medicine Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Genomic Medicine Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Genomic Medicine Market Dynamics
11.1 Genomic Medicine Industry Trends
11.2 Genomic Medicine Market Drivers
11.3 Genomic Medicine Market Challenges
11.4 Genomic Medicine Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
